Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
2,029
Views
6
CrossRef citations to date
0
Altmetric
Coronavirus – Letters

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy

Gaurav Joshia School of Pharmacy, Graphic Era Hill University, Dehradun, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7812-2871View further author information
ORCID Icon &
Ramarao Podurib GITAM Institute of Pharmacy, GITAM University, Visakhapatnam, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8144-349XView further author information
ORCID Icon
Article: 2034458 | Received 07 Jan 2022, Accepted 22 Jan 2022, Published online: 03 Mar 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.